Diversity, Equity, and Inclusion
-
Our commitment to diversity, equity and inclusion (DE&I) through our internal operations and
our approach to external collaboration is a critical part of how we fulfill our mission to
leverage Japanese innovation against neglected infectious diseases through R&D and global
partnerships.
As part of this commitment, we proudly support the UN Global Compact Women's Empowerment Principles (WEPs) as a guiding framework that strengthens our approach to gender equality in both our organizational practices and global health R&D partnerships.( Our Support for the UN Women's Empowerment Principles )
In addition, our Diversity Steering Committee, chaired by our CEO, launched in April 2024 to advance our objectives and track our progress. Learn more about how DE&I is hardwired in our DNA here .
- Diversity
- We believe that diverse perspectives drive innovation and excellence. We celebrate diversity in all its forms, and we are dedicated to diversifying our team and partnerships to mirror the global health community and value different viewpoints for informed decision-making.
- Equity
- We acknowledge persisting global health R&D disparities and commit to helping address them by focusing on funding gaps and connecting underrepresented voices. Our supported R&D prioritizes marginalized populations and removing barriers to access.
- Inclusion
- We aim to foster an inclusive, supportive environment where everyone feels valued and heard. We promote open communication, collaboration, and belonging among our staff, partners, and communities. Our culture values empathy, learning, and inclusive participation in our mission.
Our people
- Our management team and Board of Directors proudly commit to advancing gender equality , diversity, and inclusive representation through our work and in our staff and leadership. We have embarked on a journey to track voluntarily provided, disaggregated data to help us understand trends, patterns, or inequities; we look forward to sharing what we learn in due course.
- BIPOC1
-
80% of Council 71% of Board 50% of Selection Committee 100% of Staff2
- Identify as female
-
0% of Council 36% of Board 50% of Selection Committee 50% of Staff2
1 BIPOC: Black, indigenous, people of color
2 Staff = 18 full-time staff members (As of March 31,2025)
2 Staff = 18 full-time staff members (As of March 31,2025)
Our partners
- We collaborate with a diverse range of researchers and organizations to ensure a broad spectrum of perspectives and expertise is informing innovation and access at every step. We actively engage with global communities, promoting capacity building and knowledge transfer to empower the global health R&D community in Japan and around the world. Learn about the policies that support our commitment to DE&I as a funder and global collaborator here.
-
Over 30%
of development partners are Japanese entities
Approximately 70%
of development partners are global partners
-
Over 20%
of development partners are
headquartered in LMICs3.
3 LMIC: Lower- and middle-income country
(Reference : World Bank Country and Lending Groups )
(Reference : World Bank Country and Lending Groups )
References
-
- Explicit commitment to gender equality
- * Sources to include for connection between addressing NTDs and women's health:
- Rules & policies relevant to our commitment to DE&I as a global partner
- Our Support for the UN Women's Empowerment Principles
Staff Story
GHIT staff members with a variety background discuss their experience in and passion for global health R&D, as well as their day-to-day work.
*Affiliation and position are as of the time of the interview.